This inventor holds 2 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Tonix Pharma Limited. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: The Innovative Contributions of Seth Lederman
Introduction
Seth Lederman is a prominent inventor based in Austin, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of synthetic chimeric poxviruses. His work has implications for live virus vaccines and pharmaceutical formulations.
Latest Patents
Seth Lederman holds a patent for synthetic chimeric poxviruses. This invention relates to synthetic chimeric poxviruses, compositions comprising such viruses, and the development and use of systems and methods for producing these synthetic chimeric poxviruses. The synthetic chimeric poxviruses are well suited for live virus vaccines and pharmaceutical formulations. He has 1 patent to his name.
Career Highlights
Seth Lederman is currently associated with Tonix Pharma Limited, where he continues to innovate in the field of biotechnology. His work focuses on advancing the understanding and application of synthetic viruses in medical science.
Collaborations
Some of his notable coworkers include David Evans and Ryan Noyce, who contribute to the collaborative efforts in research and development at Tonix Pharma Limited.
Conclusion
Seth Lederman's innovative work in synthetic chimeric poxviruses showcases his commitment to advancing medical science and improving vaccine development. His contributions are vital to the ongoing evolution of biotechnology.